Change Starts Here.
We're Building a Future Where Brain Disorders Are Detected Earlier and Every Brain-Related Decision Is Guided by Objective Evidence.
Used by the world's leading healthcare institutions
%202.svg)
About QuantalX™
At QuantalX™, we are redefining brain healthcare by empowering clinicians with real-time, accurate insights that eliminate guesswork and accelerate decision-making. Our mission is to close critical diagnostic gaps and enable earlier, more precise intervention for neurological conditions.
We envision a future where functional brain assessments are accessible at every point of care, transforming how brain disorders are detected, managed, and treated. We aim to set a new gold standard in neurodiagnostics, driving better outcomes and a higher quality of life across the neurological spectrum.
Our Leadership Team
Decades of combined experience in neuroscience, clinical research, and medical technology.
Advisory Board
Guided by world-renowned experts in neurology and neuroscience to ensure the highest standards of clinical excellence.
Weill Cornell Medical College, New York.
Former director of combat casualty care and brain health program in the US Army.
Member of the ANA, AHA and NSA.
Leader in health policy and reimbursement.
Boston Scientific.
Boston Scientific.
In Memory of
Prof. Mark Hallett, MD. 1943–2025
We proudly remember Prof. Mark Hallett, a pioneering neurologist, longtime member of the QuantalX Advisory Board, and a dear friend.
Mark was one of the world’s leading voices in clinical neurophysiology and a pioneer in the use of transcranial magnetic stimulation to understand human brain function. His scientific curiosity, generosity, and belief in advancing the field helped inspire and guide our journey at QuantalX.
We are deeply grateful for his wisdom, friendship, and the lasting contribution he made to our work.
His legacy continues to inspire us as we work to advance the understanding of brain function and improve neurological care.
Global Footprint & Impact
QuantalX™ solutions are used in clinics and research sites across Europe, Asia, and North America, improving neurodiagnosis timelines and therapeutic selection.
.png)
Regulatory clearance and quality certification
